Latest filing published 21 May 2025 for TriSalus Life Sciences, Inc., €207k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Sean Murphy is a declared insider at 2 companies (board member); the most frequent names are TriSalus Life Sciences, Inc. and Radius Health, Inc. We count 6 filings; the first trade dates from 14 January 2022 and the latest from 19 May 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 21 May 2025, the filings show a share grant worth €207k in TriSalus Life Sciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations